Literature DB >> 33672170

Diversity of Oxacillinases and Sequence Types in Carbapenem-Resistant Acinetobacter baumannii from Austria.

Andrea J Grisold1, Josefa Luxner1, Branka Bedenić2, Magda Diab-Elschahawi3, Michael Berktold4, Agnes Wechsler-Fördös5, Gernot E Zarfel1.   

Abstract

Carbapenem-resistant Acinetobacter baumannii is a significant health problem worldwide. A multicenter study on A. baumannii was performed to investigate the molecular epidemiology and genetic background of carbapenem resistance of A. baumannii isolates collected from 2014-2017 in Austria. In total, 117 non-repetitive Acinetobacter spp. assigned to A. baumannii (n = 114) and A. pittii (n = 3) were collected from four centers in Austria. The isolates were uniformly resistant to piperacillin/tazobactam, ceftazidime, and carbapenems, and resistance to imipenem and meropenem was 97.4% and 98.2%, respectively. The most prominent OXA-types were OXA-58-like (46.5%) and OXA-23-like (41.2%), followed by OXA-24-like (10.5%), with notable regional differences. Carbapenem-hydrolyzing class D carbapenemases (CHDLs) were the only carbapenemases found in A.baumannii isolates in Austria since no metallo-β-lactamases (MBLs) nor KPC or GES carbapenemases were detected in any of the isolates. One-third of the isolates harbored multiple CHDLs. The population structure of A. baumannii isolates from Austria was found to be very diverse, while a total of twenty-three different sequence types (STs) were identified. The most frequent was ST195 found in 15.8%, followed by ST218 and ST231 equally found in 11.4% of isolates. Two new ST types, ST2025 and ST2026, were detected. In one A. pittii isolate, blaOXA-143-like was detected for the first time in Austria.

Entities:  

Keywords:  Acinetobacter baumannii; Acinetobacter pittii; OXA carbapenemases; OXA-143; OXA-23; imipenem; meropenem

Mesh:

Substances:

Year:  2021        PMID: 33672170      PMCID: PMC7926329          DOI: 10.3390/ijerph18042171

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  58 in total

1.  Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae.

Authors:  Caroline Dallenne; Anaelle Da Costa; Dominique Decré; Christine Favier; Guillaume Arlet
Journal:  J Antimicrob Chemother       Date:  2010-01-12       Impact factor: 5.790

2.  Novel acquired metallo-beta-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea.

Authors:  Kyungwon Lee; Jong Hwa Yum; Dongeun Yong; Hyuk Min Lee; Heung Dong Kim; Jean-Denis Docquier; Gian Maria Rossolini; Yunsop Chong
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

3.  Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe.

Authors:  Sophie Marqué; Laurent Poirel; Claire Héritier; Sylvain Brisse; Maria Dolores Blasco; Roxana Filip; Gabriela Coman; Thierry Naas; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

4.  Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.

Authors:  Neil Woodford; Matthew J Ellington; Juliana M Coelho; Jane F Turton; M Elaina Ward; Susan Brown; Sebastian G B Amyes; David M Livermore
Journal:  Int J Antimicrob Agents       Date:  2006-03-24       Impact factor: 5.283

Review 5.  The rise of carbapenem-resistant Acinetobacter baumannii.

Authors:  Benjamin A Evans; Ahmed Hamouda; Sebastian G B Amyes
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

6.  [Panorama of carbapenemases in PeruUm panorama das carbapenemases presentes no Peru].

Authors:  Eddie Angles-Yanqui; Jorge Huaringa-Marcelo; Rosa Sacsaquispe-Contreras; Luis Pampa-Espinoza
Journal:  Rev Panam Salud Publica       Date:  2020-09-23

7.  Dissemination of multidrug-resistant Acinetobacter baumannii genotypes carrying bla(OXA-23) collected from hospitals in Rio de Janeiro, Brazil.

Authors:  Karyne Rangel Carvalho; Ana Paula D'Alincourt Carvalho-Assef; Gisele Peirano; Lia Cristina Galvão Dos Santos; Maria José Felix Pereira; Marise Dutra Asensi
Journal:  Int J Antimicrob Agents       Date:  2009-02-11       Impact factor: 5.283

8.  Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit.

Authors:  A Tsakris; A Ikonomidis; A Poulou; N Spanakis; D Vrizas; M Diomidous; S Pournaras; F Markou
Journal:  Clin Microbiol Infect       Date:  2008-04-05       Impact factor: 8.067

Review 9.  Acinetobacter baumannii - a neglected pathogen in veterinary and environmental health in Germany.

Authors:  Gamal Wareth; Heinrich Neubauer; Lisa D Sprague
Journal:  Vet Res Commun       Date:  2018-12-27       Impact factor: 2.459

10.  Characteristics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011-2018.

Authors:  Agnieszka Litwin; Olga Fedorowicz; Wieslawa Duszynska
Journal:  Int J Environ Res Public Health       Date:  2020-09-23       Impact factor: 3.390

View more
  2 in total

1.  A Variant Carbapenem Inactivation Method (CIM) for Acinetobacter baumannii Group with Shortened Time-to-Result: rCIM-A.

Authors:  Dieter Mitteregger; Julian Wessely; Ivan Barišić; Branka Bedenić; Dieter Kosak; Michael Kundi
Journal:  Pathogens       Date:  2022-04-18

2.  Genotypic and Phenotypic Characterization of Novel Sequence Types of Carbapenem-Resistant Acinetobacter baumannii, With Heterogeneous Resistance Determinants and Targeted Variations in Efflux Operons.

Authors:  Srinivasan Vijaya Bharathi; Manjunath Venkataramaiah; Govindan Rajamohan
Journal:  Front Microbiol       Date:  2021-12-23       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.